DINAMIQS enhances gene therapy efficacy and safety with Swiss-quality manufacturing and seamless scalability. Our science-driven platform delivers optimized yields, in-house analytics, and personalized support, backed by Siegfried's century of pharmaceutical expertise. Trusted by biotech and pharma, we transform genetic medicine into success stories.
May 6, 15:15 - 15:30, room Osaka/Samarkand
Name | Position | Institution |
---|---|---|
Martin Kessler | CEO |